|
|
||||||||
The Journal of Immunology, Vol 155, Issue 12 5631-5636, Copyright © 1995 by American Association of Immunologists
ARTICLES |
H Taniguchi, M Abe, T Shirai, K Fukao and H Nakauchi
Department of Immunology, Center for Tsukuba Advanced Research Alliance, Japan.
Although allogeneic bone marrow (BM) transplantation is an effective way to induce donor-specific tolerance, its clinical application is hampered because of the risk associated with vigorous myeloablative pretransplant conditioning. One approach to overcome this problem is to establish a lower chimeric state by mild myeloablation. It is not clear, however, whether there is a threshold in the extent of chimerism that is required for tolerance induction. In this study, we establish a mixed BM chimera system to examine the correlation between the reconstitution ratio of BM chimerism, donor-reactive T cell deletion, and skin graft acceptance using I-E alpha transgenic C57BL/6 mice as the BM and skin graft donors and Ly5 congenic C57BL/6 mice as the recipients. In this system, the class II MHC molecule I-E was the transplantation Ag, and the extent of I-E-reactive T cell deletion was determined by flow cytometry using a mAb specific for the V beta 11 TCR. The degree of BM chimerism was measured by examining the expression of donor-derived Ly5.2 and host-derived Ly5.1 on peripheral blood cells. Transplantation of I-E+ transgenic donor BM cells resulted in deletion of V beta 11+CD4+ T cells in recipient's PBL, and the extent of deletion was proportional to the degree of chimerism. When mice of different degrees of chimerism were tested for skin graft survival, we found that recipient mice with > 30% chimerism could accept skin grafts from I-E+ donor mice, whereas those with < 10% chimerism showed prolonged but not permanent graft survival. These findings revealed the sequence of events for induction of tolerance. First, the degree of BM chimerism determines the number of I-E+ cells in the thymus, which then elicits negative selection of I-E-reactive T cells in a form of clonal deletion. The extent of T cell deletion ultimately determines the mode of tolerance. These data provide experimental evidence for the potential use of partial chimerism by bone marrow transplantation for the induction of donor-specific tolerance in clinical settings.
This article has been cited by other articles:
![]() |
T. Onodera, J. C. Poe, T. F. Tedder, and T. Tsubata CD22 Regulates Time Course of Both B Cell Division and Antibody Response J. Immunol., January 15, 2008; 180(2): 907 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bhattacharya, D. J. Rossi, D. Bryder, and I. L. Weissman Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning J. Exp. Med., January 23, 2006; 203(1): 73 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kanamoto and T. Maki Chimeric Donor Cells Play an Active Role in Both Induction and Maintenance Phases of Transplantation Tolerance Induced by Mixed Chimerism J. Immunol., February 1, 2004; 172(3): 1444 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zoller Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host J. Immunol., December 15, 2003; 171(12): 6941 - 6953. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hummel, D. Wilms, M. Vitacolonna, and M. Zoller Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host J. Leukoc. Biol., November 1, 2002; 72(5): 898 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayashi, J. Toki, L. Zhexiong, K. Sugiura, K. Inoue, and S. Ikehara Long-Term (>1 year) Analyses of Chimerism and Tolerance in Mixed Allogeneic Chimeric Mice Using Normal Mouse Combinations Stem Cells, July 1, 2000; 18(4): 273 - 280. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |